

Author: Yu D. S. Hsieh D. S. Chang S. Y.
Publisher: Informa Healthcare
ISSN: 1521-0375
Source: Archives of Andrology, Vol.52, Iss.5, 2006-09, pp. : 389-395
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The dynamic translocation of androgen receptors (ARs) in prostate cancer cells after hormone conversion was studied. The prostate cancer cell line LNCaP was converted into androgen-independent sublines after long-term treatment with 5α-reductase inhibitor and steroid-depleted medium. Immunohistochemical, immunofluorescent staining and laser scanning microscopy were used to observe the redistribution and serial translocation of ARs in these tumor cells. The androgen-independent tumor cells (LNCaP/Fin and LNCaP/HR) grew slower than native cells with fibroblastic-like characteristics. On immunohistochemical and immunofluorescent double staining, translocation and exocytosis of ARs were noted in androgen- independent tumor cells much more markedly than in native cells. Furthermore, laser-scanning microscopy revealed serial image changes of AR vesicle shifting and exocytosis in androgen-converted tumor cells. Translocation and exocytosis processes were observed in androgen-independent prostate cancer cells. ARs lose partly normal cellular biologic role during hormone manipulation.
Related content




Role of Chemotherapy in Hormone-Refractory Prostate Cancer
Urologia Internationalis, Vol. 70, Iss. 1, 2003-02 ,pp. :


A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer
Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. :


Hormonal Sensitivity following Endocrine Withdrawal in Hormone-Refractory Prostate Cancer
Urologia Internationalis, Vol. 65, Iss. 1, 2000-08 ,pp. :


Present Status and Perspectives in the Treatment of Hormone-Refractory Prostate Cancer
Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. :